Cynthia Cai

Newark, Delaware, United States
Dr. Cynthia Cai is an executive and investor with over twenty-five years of experience in the healthcare and life science industry. Dr. Cai has extensive experience in equity investment, board membership, marketing, and business development. Her in-depth understanding of global biotech and life science business has garnered wide recognition of her unique ability to foster collaboration between eastern and western scientists and businesses.

Dr. Cai is the founder and president of Tharton Consulting, which provides investment and management consulting services. She is also a venture partner of Viva BioInnovator, an equity investor in biotech innovation with novel solutions to cross multiple therapeutic areas. Before that, she served as senior advisor to Northern Light Venture Capital's healthcare investment effort in the United States. Previously Dr. Cai had progressive leadership roles with Agilent Technologies such as Global Associate Vice President of Marketing, where she was responsible for its billion-dollar Chromatography, Automation, and Mass Spec. business.

Dr. Cai serves on the board of directors for Spectral MD (London: SMD), Arthrosi Therapeutics, F5 Therapeutics, AceLink Therapeutics, and Amberstone Biosciences. She is also a member of the board for the Science History Institute in Philadelphia.

Dr. Cai earned a B.A. and M. Eng. from Tsinghua University in Beijing, received her Ph.D. in Chemistry from the University of Massachusetts, and an MBA from The Wharton Business School of the University of Pennsylvania.
Speaking In
1:00 PM - 2:00 PM (PDT)
Monday, June 13
Innovation and patients have brought us all closer than ever before despite an uncertain…